Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation

John R. Gasdaska, D. Lynn Kirkpatrick, William "Bill" Montfort, Miles Kuperus, Simon R. Hill, Margareta Berggren, Garth Powis

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Thioredoxin (Trx) is a widely distributed redox protein that regulates several intracellular redox-dependent processes and stimulates the proliferation of both normal and tumor cells. We have found that when stored in the absence of reducing agents, human recombinant Trx undergoes spontaneous oxidation, losing its ability to stimulate cell growth, but is still a substrate for NADPH-dependent reduction by human thioredoxin reductase. There is a slower spontaneous conversion of Trx to a homodimer that is not a substrate for reduction by thioredoxin reductase and that does not stimulate cell proliferation. Both conversions can be induced by chemical oxidants and are reversible by treatment with the thiol reducing agent dithiothreitol. SDS-PAGE suggests that Trx undergoes oxidation to monomeric form(s) preceding dimer formation. We have recently shown by X-ray crystallography that Trx forms a dimer that is stabilized by an intermolecular Cys73-Cys73 disulfide bond. A Cys73 → Ser mutant Trx (C73S) was prepared to determine the role of Cys73 in oxidative stability and growth stimulation. C73S was as effective as Trx in stimulating cell growth and was a comparable substrate for thioredoxin reductase. C73S did not show spontaneous or oxidant-induced loss of activity and did not form a dimer. The results suggest that Trx can exist in monomeric forms, some of which are mediated by Cys73 that do not stimulate cell proliferation but can be reduced by thioredoxin reductase. Cys73 is also involved in formation of an enzymatically inactive homodimer, which occurs on long term storage or by chemical oxidation. Thus, although clearly involved in protein inactivation, Cys73 is not necessary for the growth stimulating activity of Trx.

Original languageEnglish (US)
Pages (from-to)1741-1747
Number of pages7
JournalBiochemical Pharmacology
Volume52
Issue number11
DOIs
StatePublished - Dec 13 1996

Fingerprint

Thioredoxins
Intercellular Signaling Peptides and Proteins
Mutation
Thioredoxin-Disulfide Reductase
Dimers
Reducing Agents
Cell proliferation
Cell growth
Growth
Oxidants
Oxidation
Oxidation-Reduction
Substrates
Cell Proliferation
Dithiothreitol
X ray crystallography
X Ray Crystallography
NADP
Sulfhydryl Compounds
Disulfides

Keywords

  • growth factor
  • homodimer
  • oxidation
  • thioredoxin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation. / Gasdaska, John R.; Kirkpatrick, D. Lynn; Montfort, William "Bill"; Kuperus, Miles; Hill, Simon R.; Berggren, Margareta; Powis, Garth.

In: Biochemical Pharmacology, Vol. 52, No. 11, 13.12.1996, p. 1741-1747.

Research output: Contribution to journalArticle

Gasdaska, John R. ; Kirkpatrick, D. Lynn ; Montfort, William "Bill" ; Kuperus, Miles ; Hill, Simon R. ; Berggren, Margareta ; Powis, Garth. / Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation. In: Biochemical Pharmacology. 1996 ; Vol. 52, No. 11. pp. 1741-1747.
@article{65e9e19811564bdda6ba392a6aa13288,
title = "Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation",
abstract = "Thioredoxin (Trx) is a widely distributed redox protein that regulates several intracellular redox-dependent processes and stimulates the proliferation of both normal and tumor cells. We have found that when stored in the absence of reducing agents, human recombinant Trx undergoes spontaneous oxidation, losing its ability to stimulate cell growth, but is still a substrate for NADPH-dependent reduction by human thioredoxin reductase. There is a slower spontaneous conversion of Trx to a homodimer that is not a substrate for reduction by thioredoxin reductase and that does not stimulate cell proliferation. Both conversions can be induced by chemical oxidants and are reversible by treatment with the thiol reducing agent dithiothreitol. SDS-PAGE suggests that Trx undergoes oxidation to monomeric form(s) preceding dimer formation. We have recently shown by X-ray crystallography that Trx forms a dimer that is stabilized by an intermolecular Cys73-Cys73 disulfide bond. A Cys73 → Ser mutant Trx (C73S) was prepared to determine the role of Cys73 in oxidative stability and growth stimulation. C73S was as effective as Trx in stimulating cell growth and was a comparable substrate for thioredoxin reductase. C73S did not show spontaneous or oxidant-induced loss of activity and did not form a dimer. The results suggest that Trx can exist in monomeric forms, some of which are mediated by Cys73 that do not stimulate cell proliferation but can be reduced by thioredoxin reductase. Cys73 is also involved in formation of an enzymatically inactive homodimer, which occurs on long term storage or by chemical oxidation. Thus, although clearly involved in protein inactivation, Cys73 is not necessary for the growth stimulating activity of Trx.",
keywords = "growth factor, homodimer, oxidation, thioredoxin",
author = "Gasdaska, {John R.} and Kirkpatrick, {D. Lynn} and Montfort, {William {"}Bill{"}} and Miles Kuperus and Hill, {Simon R.} and Margareta Berggren and Garth Powis",
year = "1996",
month = "12",
day = "13",
doi = "10.1016/S0006-2952(96)00595-3",
language = "English (US)",
volume = "52",
pages = "1741--1747",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation

AU - Gasdaska, John R.

AU - Kirkpatrick, D. Lynn

AU - Montfort, William "Bill"

AU - Kuperus, Miles

AU - Hill, Simon R.

AU - Berggren, Margareta

AU - Powis, Garth

PY - 1996/12/13

Y1 - 1996/12/13

N2 - Thioredoxin (Trx) is a widely distributed redox protein that regulates several intracellular redox-dependent processes and stimulates the proliferation of both normal and tumor cells. We have found that when stored in the absence of reducing agents, human recombinant Trx undergoes spontaneous oxidation, losing its ability to stimulate cell growth, but is still a substrate for NADPH-dependent reduction by human thioredoxin reductase. There is a slower spontaneous conversion of Trx to a homodimer that is not a substrate for reduction by thioredoxin reductase and that does not stimulate cell proliferation. Both conversions can be induced by chemical oxidants and are reversible by treatment with the thiol reducing agent dithiothreitol. SDS-PAGE suggests that Trx undergoes oxidation to monomeric form(s) preceding dimer formation. We have recently shown by X-ray crystallography that Trx forms a dimer that is stabilized by an intermolecular Cys73-Cys73 disulfide bond. A Cys73 → Ser mutant Trx (C73S) was prepared to determine the role of Cys73 in oxidative stability and growth stimulation. C73S was as effective as Trx in stimulating cell growth and was a comparable substrate for thioredoxin reductase. C73S did not show spontaneous or oxidant-induced loss of activity and did not form a dimer. The results suggest that Trx can exist in monomeric forms, some of which are mediated by Cys73 that do not stimulate cell proliferation but can be reduced by thioredoxin reductase. Cys73 is also involved in formation of an enzymatically inactive homodimer, which occurs on long term storage or by chemical oxidation. Thus, although clearly involved in protein inactivation, Cys73 is not necessary for the growth stimulating activity of Trx.

AB - Thioredoxin (Trx) is a widely distributed redox protein that regulates several intracellular redox-dependent processes and stimulates the proliferation of both normal and tumor cells. We have found that when stored in the absence of reducing agents, human recombinant Trx undergoes spontaneous oxidation, losing its ability to stimulate cell growth, but is still a substrate for NADPH-dependent reduction by human thioredoxin reductase. There is a slower spontaneous conversion of Trx to a homodimer that is not a substrate for reduction by thioredoxin reductase and that does not stimulate cell proliferation. Both conversions can be induced by chemical oxidants and are reversible by treatment with the thiol reducing agent dithiothreitol. SDS-PAGE suggests that Trx undergoes oxidation to monomeric form(s) preceding dimer formation. We have recently shown by X-ray crystallography that Trx forms a dimer that is stabilized by an intermolecular Cys73-Cys73 disulfide bond. A Cys73 → Ser mutant Trx (C73S) was prepared to determine the role of Cys73 in oxidative stability and growth stimulation. C73S was as effective as Trx in stimulating cell growth and was a comparable substrate for thioredoxin reductase. C73S did not show spontaneous or oxidant-induced loss of activity and did not form a dimer. The results suggest that Trx can exist in monomeric forms, some of which are mediated by Cys73 that do not stimulate cell proliferation but can be reduced by thioredoxin reductase. Cys73 is also involved in formation of an enzymatically inactive homodimer, which occurs on long term storage or by chemical oxidation. Thus, although clearly involved in protein inactivation, Cys73 is not necessary for the growth stimulating activity of Trx.

KW - growth factor

KW - homodimer

KW - oxidation

KW - thioredoxin

UR - http://www.scopus.com/inward/record.url?scp=0030582835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030582835&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(96)00595-3

DO - 10.1016/S0006-2952(96)00595-3

M3 - Article

C2 - 8986137

AN - SCOPUS:0030582835

VL - 52

SP - 1741

EP - 1747

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 11

ER -